Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases | MicrobiomeTrials← Back to trialsNCT06013423
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-07-23Est. Completion: 2031-10-31
Enrollment target: 54 participants Locations- Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Other microbiome trials you might be interested in
B-cell Acute Lymphoblastic LeukemiaLarge B-cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMarginal Zone LymphomaFollicular LymphomaMantle Cell LymphomaDiffuse Large B Cell LymphomaHigh-grade B-cell LymphomaBurkitt LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)Non Hodgkin LymphomaMixed Phenotype Acute Leukemia
This is a Phase 1/2, first-in-human, open-label, dose-escalating trial designed to assess the safety and efficacy of VNX…
Duarte, United StatesEst. completion Jun 2027
Drug Toxicity
This research study is being done to learn more about the short term and long term side effects of treatment with aspara…
Memphis, United StatesEst. completion Jul 2030